Mizuho Securities has lowered its price target on Tesla Inc. (NASDAQ: TSLA) to $325 from $375 after the EV giant reported disappointing Q1 results. Despite the downgrade, the brokerage maintained its "Outperform" rating, citing optimism around Tesla’s upcoming low-cost models and autonomous vehicle ambitions.
Tesla’s first-quarter earnings fell short on both top and bottom lines. The company posted earnings per share of $0.27, missing Wall Street’s estimate of $0.44. Revenue also came in below expectations at $19.3 billion versus the $21.4 billion consensus. Mizuho noted the underperformance was anticipated, yet still sees an 8% year-over-year decline in Tesla’s 2025 deliveries, following the firm’s withdrawal of its annual guidance.
However, Mizuho remains bullish on Tesla’s longer-term growth potential. Analysts highlighted the expected launch of a low-cost Model Y in the first half of 2025 and the rollout of Tesla’s autonomous Cybercab in early 2026 as key catalysts. Despite reports suggesting delays to 2026, Mizuho believes the Model Y launch is still on track, though production ramp-up may be slower than initially projected.
The brokerage emphasized Tesla’s continued leadership in the U.S. EV market, which could help cushion losses stemming from fierce competition and political backlash in China and parts of Europe.
Elon Musk, Tesla’s CEO, also pledged to shift focus back to the company by stepping back from his government-related duties starting in May—a move that sparked a rally in Tesla shares despite weak earnings.
With Tesla navigating challenges from global EV competition and political scrutiny, Mizuho sees its innovation pipeline as a critical driver of future growth.


Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Washington Post Publisher Will Lewis Steps Down After Layoffs
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 



